Phage therapy for knee or hip joint infections caused by staph bacteria
Treatments studied
Part of Bones, joints & muscles, Infections clinical trials.
This trial tests a new treatment using viruses that attack bacteria (called phages) to fight infections in knee or hip replacements caused by Staphylococcus aureus. It may help people who still have the infection after a surgery to clean the joint, called DAIR.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an infection in your hip or knee replacement caused by a bacteria called Staphylococcus aureus (staph).
- You are scheduled to have or recently had a procedure to clean the joint (called DAIR).
- You are not currently in severe sepsis or septic shock, and your health is generally stable.
- You are willing to use effective birth control during the study if you or your partner can have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a treatment with special viruses (called phages) to standard antibiotic care can help clear a joint infection more effectively after surgery. The goal is to improve your chances of keeping the artificial hip or knee and avoid the need for more procedures.
This trial studies a treatment using viruses that attack bacteria (called phages) to fight a stubborn joint infection that hasn't improved with other treatments. It may help people with chronic infections that resist antibiotics.
This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.
This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.
This trial tests a new medicine called PLG0206 to help prevent a knee infection from coming back after a procedure to clean the joint while keeping the artificial knee in place. If you qualify, you'll receive the study medicine or a placebo along with standard antibiotics.
This trial tests whether giving antibiotics directly into the knee through a small tube can help clear an infection that develops after a knee replacement surgery. It aims to improve the success of a procedure called DAIR, which is used to treat early knee joint infections.
Hear when a new Hip Prosthesis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.